Suppr超能文献

脑静脉血栓形成导致后颅窝病变:病例系列描述和抗凝安全性评估。

Cerebral venous thrombosis causing posterior fossa lesions: description of a case series and assessment of safety of anticoagulation.

出版信息

Cerebrovasc Dis. 2014;38(5):384-8. doi: 10.1159/000368999. Epub 2014 Nov 25.

Abstract

BACKGROUND

Isolated posterior fossa parenchymal lesions associated with cerebral venous thrombosis (CVT) are rare. Posterior fossa lesions are an independent predictor of death in CVT. We aim to describe the characteristics and outcome of patients with CVT and isolated posterior fossa lesions and assess the safety of anticoagulation in patients with posterior fossa lesions associated with CVT.

METHODS

We retrieved data from all patients with posterior fossa parenchymal lesions in the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) cohort related to clinical features, therapy and outcome. Fisher's exact test was used to evaluate associations. To assess the safety of anticoagulation in CVT patients with posterior fossa lesions we considered all patients with a lesion in this topography, either isolated or with concomitant supratentorial lesions, and compared the rate of new intracranial haemorrhages on repeated imaging with the remaining cohort.

RESULTS

Out of 624 patients, 12 had isolated posterior fossa lesions and 14 had posterior fossa lesion with accompanying supratentorial lesions. The lateral sinus was most frequently occluded (n = 11). Involvement of the superior sagittal sinus was significantly less frequent compared to the remaining patients of the cohort (p = 0.013). None of the patients with isolated posterior fossa lesion died but 3 remained dependent on follow-up. Poor outcome (modified Rankin Scale ≥3) was more frequent in patients with any posterior fossa lesion, even when on anticoagulation (29.2% vs. 11.9%; OR 3.04; 95% CI 1.2-7.6; p = 0.018). Of the 24 anticoagulated patients with a posterior fossa lesion, 3 (12.5%) had new haemorrhages on repeated imaging, compared with 30 out of 495 anticoagulated patients (6.1%) without posterior fossa lesions (p = 0.19).

CONCLUSIONS

We describe the largest series of CVT patients with associated posterior fossa lesions. When compared to anticoagulated CVT patients without posterior fossa lesions, CVT patients with posterior fossa lesions on full anticoagulation did not have a significant increase in the rate of new intracranial haemorrhages.

摘要

背景

孤立性颅后窝实质病变与脑静脉血栓形成(CVT)相关较为罕见。颅后窝病变是 CVT 患者死亡的独立预测因素。本研究旨在描述 CVT 合并孤立性颅后窝病变患者的特征和结局,并评估 CVT 合并颅后窝病变患者抗凝治疗的安全性。

方法

我们从国际脑静脉和硬脑膜窦血栓形成研究(ISCVT)队列中检索与临床特征、治疗和结局相关的所有颅后窝实质病变患者的数据。采用 Fisher 确切检验评估相关性。为评估 CVT 患者颅后窝病变抗凝治疗的安全性,我们考虑了所有存在该部位病变的患者,无论病变是否孤立或伴有幕上病变,并将重复影像学检查中新出现颅内出血的发生率与其余队列进行比较。

结果

在 624 例患者中,12 例为孤立性颅后窝病变,14 例为颅后窝病变伴幕上病变。最常发生闭塞的是外侧窦(n = 11)。与队列中其余患者相比,上矢状窦受累的频率明显较低(p = 0.013)。孤立性颅后窝病变患者无一例死亡,但 3 例患者仍依赖随访。任何颅后窝病变患者的预后不良(改良 Rankin 量表≥3)更为常见,即使接受抗凝治疗也是如此(29.2%比 11.9%;OR 3.04;95%CI 1.2-7.6;p = 0.018)。在 24 例接受抗凝治疗的颅后窝病变患者中,有 3 例(12.5%)在重复影像学检查时出现新的出血,而在 495 例未接受颅后窝病变抗凝治疗的患者中,有 30 例(6.1%)出现新的出血(p = 0.19)。

结论

我们描述了最大的 CVT 合并颅后窝病变患者系列。与未接受颅后窝病变抗凝治疗的 CVT 患者相比,接受充分抗凝治疗的 CVT 合并颅后窝病变患者颅内出血新发生率无显著增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验